Laboratory of Vascular Biology, Department of Molecular and Cellular Pathology and Therapy, Instituto de Biomedicina de Valencia-CSIC, C/Jaime Roig 11, 46010 Valencia, Spain.
Cardiovasc Res. 2010 May 1;86(2):254-64. doi: 10.1093/cvr/cvp363. Epub 2009 Nov 9.
Excessive hyperplastic cell growth within occlusive vascular lesions has been recognized as a key component of the inflammatory response associated with atherosclerosis, restenosis post-angioplasty, and graft atherosclerosis after coronary artery bypass. Understanding the molecular mechanisms that regulate arterial cell proliferation is therefore essential for the development of new tools for the treatment of these diseases. Mammalian cell proliferation is controlled by a large number of proteins that modulate the mitotic cell cycle, including cyclin-dependent kinases, cyclins, and tumour suppressors. The purpose of this review is to summarize current knowledge about the role of these cell cycle regulators in the development of native and graft atherosclerosis that has arisen from animal studies, histological examination of specimens from human patients, and genetic studies.
细胞过度增生是血管阻塞性病变中炎症反应的一个关键组成部分,这与动脉粥样硬化、血管成形术后再狭窄以及冠状动脉旁路移植后的移植物动脉粥样硬化等疾病有关。因此,了解调节动脉细胞增殖的分子机制对于开发治疗这些疾病的新方法至关重要。有大量蛋白可调节细胞有丝分裂周期,从而控制哺乳动物细胞的增殖,这些蛋白包括细胞周期蛋白依赖性激酶、细胞周期蛋白和肿瘤抑制因子。本文综述了这些细胞周期调控因子在动物研究、人类患者标本的组织学检查和遗传研究中对原发性和移植性动脉粥样硬化发生发展的作用。